rs774306610
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_183050.4(BCKDHB):c.564T>A(p.Cys188*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_183050.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- maple syrup urine disease type 1BInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
- maple syrup urine diseaseInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- classic maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermittent maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thiamine-responsive maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BCKDHB | NM_183050.4 | c.564T>A | p.Cys188* | stop_gained | Exon 5 of 10 | ENST00000320393.9 | NP_898871.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCKDHB | ENST00000320393.9 | c.564T>A | p.Cys188* | stop_gained | Exon 5 of 10 | 1 | NM_183050.4 | ENSP00000318351.5 | ||
| BCKDHB | ENST00000356489.9 | c.564T>A | p.Cys188* | stop_gained | Exon 5 of 11 | 1 | ENSP00000348880.5 | |||
| BCKDHB | ENST00000369760.8 | c.564T>A | p.Cys188* | stop_gained | Exon 5 of 6 | 3 | ENSP00000358775.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251402 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461854Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:2
This sequence change creates a premature translational stop signal (p.Cys188*) in the BCKDHB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BCKDHB are known to be pathogenic (PMID: 16786533, 22593002). This variant is present in population databases (rs774306610, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with maple syrup urine disease (PMID: 19480318). ClinVar contains an entry for this variant (Variation ID: 580585). For these reasons, this variant has been classified as Pathogenic. -
This is a null variant in a gene where the loss of function is a known disease mechanism, resulting in a truncated protein creating a premature stop codon. It is present in population databases in low frequency (gnomAD exomes: 0,00001; ExAC: 0,000008). This variant has been published in the literature associated with individuals with MSUD (PMID: 19480318). -
Maple syrup urine disease type 1B Pathogenic:1
- -
Maple syrup urine disease type 1A Pathogenic:1
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000580585 /PMID: 19480318 /3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at